- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Neurological Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Neurological Biomarkers market size is estimated to be worth US$ 7137.8 million in 2021 and is forecast to a readjusted size of USD 15280 million by 2028 with a CAGR of 11.5% during review period. Diagnostics accounting for % of the Neurological Biomarkers global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Proteomics segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Neurological Biomarkers include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, and Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Neurological Biomarkers market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Proteomics
Genomics
Imaging
Bioinformatics
Others
Market segment by Application can be divided into
Diagnostics
Drug Discovery
Personalized Medicine
Others
The key market players for global Neurological Biomarkers market are listed below:
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurological Biomarkers product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neurological Biomarkers, with price, sales, revenue and global market share of Neurological Biomarkers from 2019 to 2022.
Chapter 3, the Neurological Biomarkers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurological Biomarkers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Neurological Biomarkers market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurological Biomarkers.
Chapter 13, 14, and 15, to describe Neurological Biomarkers sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Neurological Biomarkers Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neurological Biomarkers Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Proteomics
1.2.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Neurological Biomarkers Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Global Neurological Biomarkers Market Size & Forecast
1.4.1 Global Neurological Biomarkers Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Neurological Biomarkers Sales in Volume (2017-2028)
1.4.3 Global Neurological Biomarkers Price (2017-2028)
1.5 Global Neurological Biomarkers Production Capacity Analysis
1.5.1 Global Neurological Biomarkers Total Production Capacity (2017-2028)
1.5.2 Global Neurological Biomarkers Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neurological Biomarkers Market Drivers
1.6.2 Neurological Biomarkers Market Restraints
1.6.3 Neurological Biomarkers Trends Analysis
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Neurological Biomarkers Product and Services
2.1.4 Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Neurological Biomarkers Product and Services
2.2.4 Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business
2.3.3 Quest Diagnostics Neurological Biomarkers Product and Services
2.3.4 Quest Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Neurological Biomarkers Product and Services
2.4.4 Abbott Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Neurological Biomarkers Product and Services
2.5.4 Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Illumina
2.6.1 Illumina Details
2.6.2 Illumina Major Business
2.6.3 Illumina Neurological Biomarkers Product and Services
2.6.4 Illumina Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Neurological Biomarkers Product and Services
2.7.4 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 QIAGEN
2.8.1 QIAGEN Details
2.8.2 QIAGEN Major Business
2.8.3 QIAGEN Neurological Biomarkers Product and Services
2.8.4 QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Myriad RBM
2.9.1 Myriad RBM Details
2.9.2 Myriad RBM Major Business
2.9.3 Myriad RBM Neurological Biomarkers Product and Services
2.9.4 Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Cisbio Bioassays
2.10.1 Cisbio Bioassays Details
2.10.2 Cisbio Bioassays Major Business
2.10.3 Cisbio Bioassays Neurological Biomarkers Product and Services
2.10.4 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Athena Diagnostics
2.11.1 Athena Diagnostics Details
2.11.2 Athena Diagnostics Major Business
2.11.3 Athena Diagnostics Neurological Biomarkers Product and Services
2.11.4 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 BGI
2.12.1 BGI Details
2.12.2 BGI Major Business
2.12.3 BGI Neurological Biomarkers Product and Services
2.12.4 BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Wuxi APP
2.13.1 Wuxi APP Details
2.13.2 Wuxi APP Major Business
2.13.3 Wuxi APP Neurological Biomarkers Product and Services
2.13.4 Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Aepodia
2.14.1 Aepodia Details
2.14.2 Aepodia Major Business
2.14.3 Aepodia Neurological Biomarkers Product and Services
2.14.4 Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Proteome Sciences
2.15.1 Proteome Sciences Details
2.15.2 Proteome Sciences Major Business
2.15.3 Proteome Sciences Neurological Biomarkers Product and Services
2.15.4 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Genewiz
2.16.1 Genewiz Details
2.16.2 Genewiz Major Business
2.16.3 Genewiz Neurological Biomarkers Product and Services
2.16.4 Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Neurological Biomarkers Breakdown Data by Manufacturer
3.1 Global Neurological Biomarkers Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Neurological Biomarkers Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Neurological Biomarkers
3.4 Market Concentration Rate
3.4.1 Top 3 Neurological Biomarkers Manufacturer Market Share in 2021
3.4.2 Top 6 Neurological Biomarkers Manufacturer Market Share in 2021
3.5 Global Neurological Biomarkers Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Neurological Biomarkers Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Neurological Biomarkers Market Size by Region
4.1.1 Global Neurological Biomarkers Sales in Volume by Region (2017-2028)
4.1.2 Global Neurological Biomarkers Revenue by Region (2017-2028)
4.2 North America Neurological Biomarkers Revenue (2017-2028)
4.3 Europe Neurological Biomarkers Revenue (2017-2028)
4.4 Asia-Pacific Neurological Biomarkers Revenue (2017-2028)
4.5 South America Neurological Biomarkers Revenue (2017-2028)
4.6 Middle East and Africa Neurological Biomarkers Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Neurological Biomarkers Sales in Volume by Type (2017-2028)
5.2 Global Neurological Biomarkers Revenue by Type (2017-2028)
5.3 Global Neurological Biomarkers Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Neurological Biomarkers Sales in Volume by Application (2017-2028)
6.2 Global Neurological Biomarkers Revenue by Application (2017-2028)
6.3 Global Neurological Biomarkers Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Neurological Biomarkers Sales by Type (2017-2028)
7.2 North America Neurological Biomarkers Sales by Application (2017-2028)
7.3 North America Neurological Biomarkers Market Size by Country
7.3.1 North America Neurological Biomarkers Sales in Volume by Country (2017-2028)
7.3.2 North America Neurological Biomarkers Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Neurological Biomarkers Sales by Type (2017-2028)
8.2 Europe Neurological Biomarkers Sales by Application (2017-2028)
8.3 Europe Neurological Biomarkers Market Size by Country
8.3.1 Europe Neurological Biomarkers Sales in Volume by Country (2017-2028)
8.3.2 Europe Neurological Biomarkers Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Neurological Biomarkers Sales by Type (2017-2028)
9.2 Asia-Pacific Neurological Biomarkers Sales by Application (2017-2028)
9.3 Asia-Pacific Neurological Biomarkers Market Size by Region
9.3.1 Asia-Pacific Neurological Biomarkers Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Neurological Biomarkers Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Neurological Biomarkers Sales by Type (2017-2028)
10.2 South America Neurological Biomarkers Sales by Application (2017-2028)
10.3 South America Neurological Biomarkers Market Size by Country
10.3.1 South America Neurological Biomarkers Sales in Volume by Country (2017-2028)
10.3.2 South America Neurological Biomarkers Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Neurological Biomarkers Sales by Type (2017-2028)
11.2 Middle East & Africa Neurological Biomarkers Sales by Application (2017-2028)
11.3 Middle East & Africa Neurological Biomarkers Market Size by Country
11.3.1 Middle East & Africa Neurological Biomarkers Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Neurological Biomarkers Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Neurological Biomarkers and Key Manufacturers
12.2 Manufacturing Costs Percentage of Neurological Biomarkers
12.3 Neurological Biomarkers Production Process
12.4 Neurological Biomarkers Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Neurological Biomarkers Typical Distributors
13.3 Neurological Biomarkers Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Neurological Biomarkers Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Neurological Biomarkers Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Scientific Major Business
Table 5. Thermo Fisher Scientific Neurological Biomarkers Product and Services
Table 6. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Neurological Biomarkers Product and Services
Table 10. Merck Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 12. Quest Diagnostics Major Business
Table 13. Quest Diagnostics Neurological Biomarkers Product and Services
Table 14. Quest Diagnostics Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Neurological Biomarkers Product and Services
Table 18. Abbott Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Roche Basic Information, Manufacturing Base and Competitors
Table 20. Roche Major Business
Table 21. Roche Neurological Biomarkers Product and Services
Table 22. Roche Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Illumina Basic Information, Manufacturing Base and Competitors
Table 24. Illumina Major Business
Table 25. Illumina Neurological Biomarkers Product and Services
Table 26. Illumina Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 28. Bio-Rad Laboratories Major Business
Table 29. Bio-Rad Laboratories Neurological Biomarkers Product and Services
Table 30. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. QIAGEN Basic Information, Manufacturing Base and Competitors
Table 32. QIAGEN Major Business
Table 33. QIAGEN Neurological Biomarkers Product and Services
Table 34. QIAGEN Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Myriad RBM Basic Information, Manufacturing Base and Competitors
Table 36. Myriad RBM Major Business
Table 37. Myriad RBM Neurological Biomarkers Product and Services
Table 38. Myriad RBM Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Cisbio Bioassays Basic Information, Manufacturing Base and Competitors
Table 40. Cisbio Bioassays Major Business
Table 41. Cisbio Bioassays Neurological Biomarkers Product and Services
Table 42. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Athena Diagnostics Basic Information, Manufacturing Base and Competitors
Table 44. Athena Diagnostics Major Business
Table 45. Athena Diagnostics Neurological Biomarkers Product and Services
Table 46. Athena Diagnostics Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. BGI Basic Information, Manufacturing Base and Competitors
Table 48. BGI Major Business
Table 49. BGI Neurological Biomarkers Product and Services
Table 50. BGI Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Wuxi APP Basic Information, Manufacturing Base and Competitors
Table 52. Wuxi APP Major Business
Table 53. Wuxi APP Neurological Biomarkers Product and Services
Table 54. Wuxi APP Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Aepodia Basic Information, Manufacturing Base and Competitors
Table 56. Aepodia Major Business
Table 57. Aepodia Neurological Biomarkers Product and Services
Table 58. Aepodia Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table 60. Proteome Sciences Major Business
Table 61. Proteome Sciences Neurological Biomarkers Product and Services
Table 62. Proteome Sciences Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Genewiz Basic Information, Manufacturing Base and Competitors
Table 64. Genewiz Major Business
Table 65. Genewiz Neurological Biomarkers Product and Services
Table 66. Genewiz Neurological Biomarkers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Neurological Biomarkers Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 68. Global Neurological Biomarkers Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Neurological Biomarkers, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Neurological Biomarkers Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Neurological Biomarkers Production Site of Key Manufacturer
Table 72. Neurological Biomarkers New Entrant and Capacity Expansion Plans
Table 73. Neurological Biomarkers Mergers & Acquisitions in the Past Five Years
Table 74. Global Neurological Biomarkers Sales by Region (2017-2022) & (K Units)
Table 75. Global Neurological Biomarkers Sales by Region (2023-2028) & (K Units)
Table 76. Global Neurological Biomarkers Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Neurological Biomarkers Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
Table 79. Global Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
Table 80. Global Neurological Biomarkers Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Neurological Biomarkers Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Neurological Biomarkers Price by Type (2017-2022) & (USD/Unit)
Table 83. Global Neurological Biomarkers Price by Type (2023-2028) & (USD/Unit)
Table 84. Global Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
Table 85. Global Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
Table 86. Global Neurological Biomarkers Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Neurological Biomarkers Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Neurological Biomarkers Price by Application (2017-2022) & (USD/Unit)
Table 89. Global Neurological Biomarkers Price by Application (2023-2028) & (USD/Unit)
Table 90. North America Neurological Biomarkers Sales by Country (2017-2022) & (K Units)
Table 91. North America Neurological Biomarkers Sales by Country (2023-2028) & (K Units)
Table 92. North America Neurological Biomarkers Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Neurological Biomarkers Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
Table 95. North America Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
Table 96. North America Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
Table 97. North America Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
Table 98. Europe Neurological Biomarkers Sales by Country (2017-2022) & (K Units)
Table 99. Europe Neurological Biomarkers Sales by Country (2023-2028) & (K Units)
Table 100. Europe Neurological Biomarkers Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Neurological Biomarkers Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
Table 103. Europe Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
Table 104. Europe Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
Table 105. Europe Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
Table 106. Asia-Pacific Neurological Biomarkers Sales by Region (2017-2022) & (K Units)
Table 107. Asia-Pacific Neurological Biomarkers Sales by Region (2023-2028) & (K Units)
Table 108. Asia-Pacific Neurological Biomarkers Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Neurological Biomarkers Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
Table 111. Asia-Pacific Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
Table 112. Asia-Pacific Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
Table 113. Asia-Pacific Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
Table 114. South America Neurological Biomarkers Sales by Country (2017-2022) & (K Units)
Table 115. South America Neurological Biomarkers Sales by Country (2023-2028) & (K Units)
Table 116. South America Neurological Biomarkers Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Neurological Biomarkers Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
Table 119. South America Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
Table 120. South America Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
Table 121. South America Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
Table 122. Middle East & Africa Neurological Biomarkers Sales by Region (2017-2022) & (K Units)
Table 123. Middle East & Africa Neurological Biomarkers Sales by Region (2023-2028) & (K Units)
Table 124. Middle East & Africa Neurological Biomarkers Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Neurological Biomarkers Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
Table 127. Middle East & Africa Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
Table 128. Middle East & Africa Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
Table 129. Middle East & Africa Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
Table 130. Neurological Biomarkers Raw Material
Table 131. Key Manufacturers of Neurological Biomarkers Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Neurological Biomarkers Typical Distributors
Table 135. Neurological Biomarkers Typical Customers
List of Figures
Figure 1. Neurological Biomarkers Picture
Figure 2. Global Neurological Biomarkers Revenue Market Share by Type in 2021
Figure 3. Proteomics
Figure 4. Genomics
Figure 5. Imaging
Figure 6. Bioinformatics
Figure 7. Others
Figure 8. Global Neurological Biomarkers Revenue Market Share by Application in 2021
Figure 9. Diagnostics
Figure 10. Drug Discovery
Figure 11. Personalized Medicine
Figure 12. Others
Figure 13. Global Neurological Biomarkers Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Neurological Biomarkers Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Neurological Biomarkers Sales (2017-2028) & (K Units)
Figure 16. Global Neurological Biomarkers Price (2017-2028) & (USD/Unit)
Figure 17. Global Neurological Biomarkers Production Capacity (2017-2028) & (K Units)
Figure 18. Global Neurological Biomarkers Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Neurological Biomarkers Market Drivers
Figure 20. Neurological Biomarkers Market Restraints
Figure 21. Neurological Biomarkers Market Trends
Figure 22. Global Neurological Biomarkers Sales Market Share by Manufacturer in 2021
Figure 23. Global Neurological Biomarkers Revenue Market Share by Manufacturer in 2021
Figure 24. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Neurological Biomarkers Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Neurological Biomarkers Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Neurological Biomarkers Sales Market Share by Region (2017-2028)
Figure 28. Global Neurological Biomarkers Revenue Market Share by Region (2017-2028)
Figure 29. North America Neurological Biomarkers Revenue (2017-2028) & (USD Million)
Figure 30. Europe Neurological Biomarkers Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Neurological Biomarkers Revenue (2017-2028) & (USD Million)
Figure 32. South America Neurological Biomarkers Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Neurological Biomarkers Revenue (2017-2028) & (USD Million)
Figure 34. Global Neurological Biomarkers Sales Market Share by Type (2017-2028)
Figure 35. Global Neurological Biomarkers Revenue Market Share by Type (2017-2028)
Figure 36. Global Neurological Biomarkers Price by Type (2017-2028) & (USD/Unit)
Figure 37. Global Neurological Biomarkers Sales Market Share by Application (2017-2028)
Figure 38. Global Neurological Biomarkers Revenue Market Share by Application (2017-2028)
Figure 39. Global Neurological Biomarkers Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Neurological Biomarkers Sales Market Share by Type (2017-2028)
Figure 41. North America Neurological Biomarkers Sales Market Share by Application (2017-2028)
Figure 42. North America Neurological Biomarkers Sales Market Share by Country (2017-2028)
Figure 43. North America Neurological Biomarkers Revenue Market Share by Country (2017-2028)
Figure 44. United States Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Neurological Biomarkers Sales Market Share by Type (2017-2028)
Figure 48. Europe Neurological Biomarkers Sales Market Share by Application (2017-2028)
Figure 49. Europe Neurological Biomarkers Sales Market Share by Country (2017-2028)
Figure 50. Europe Neurological Biomarkers Revenue Market Share by Country (2017-2028)
Figure 51. Germany Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Neurological Biomarkers Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Neurological Biomarkers Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Neurological Biomarkers Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Neurological Biomarkers Revenue Market Share by Region (2017-2028)
Figure 60. China Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Neurological Biomarkers Sales Market Share by Type (2017-2028)
Figure 67. South America Neurological Biomarkers Sales Market Share by Application (2017-2028)
Figure 68. South America Neurological Biomarkers Sales Market Share by Country (2017-2028)
Figure 69. South America Neurological Biomarkers Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Neurological Biomarkers Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Neurological Biomarkers Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Neurological Biomarkers Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Neurological Biomarkers Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Neurological Biomarkers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Neurological Biomarkers in 2021
Figure 81. Manufacturing Process Analysis of Neurological Biomarkers
Figure 82. Neurological Biomarkers Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
